The Wall Street Journal Weighs in on Gene-Editing Technology

Read the recent Wall Street Journal article featuring Dr. Jennifer Doudna's Crispr-CAS9 research, Why Gene-Editing Technology Has Scientists Excited: Researchers explore the idea of treating disease by replacing defective genes.